Snapshot from Aug 03, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Pfizer suspends Premarin cream in India
Business product suspension

Pfizer suspends Premarin cream in India

Analysis based on 6 articles · First reported Jul 16, 2026 · Last updated Jul 17, 2026

Sentiment
-10
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The suspension may slightly reduce Pfizer's revenue in India but is immaterial to overall financials. It could benefit Torrent Pharmaceuticals' Evalon as patients seek alternatives, while highlighting supply chain risks in the estrogen therapy market.

Pharmaceuticals Healthcare
Event Summary

Pfizer has temporarily discontinued Premarin vaginal cream in India due to supply challenges, affecting millions of women who rely on it for menopause symptoms. The cream held 37% of India's conjugated estrogen market by value, with sales of 266 million rupees ($2.76 million) in the year to June 2026. Alternatives are limited, with only Evalon from Torrent Pharmaceuticals available. Pfizer stated the discontinuation has no material financial impact. The event highlights supply vulnerabilities in a growing market projected to reach $604.6 million by 2033.

Key Actions
80 Pfizer suspended sales
Entities Involved
stock
Pfizer
Pfizer temporarily discontinued Premarin cream in India due to supply challenges, with no material financial impact expected.
Importance 100.0 Sentiment -10.0
cnt
India
India faces reduced access to estrogen therapy for millions of menopausal women, highlighting gaps in treatment options.
Importance 80.0 Sentiment -20.0
stock
Torrent Pharmaceuticals
Torrent's Evalon cream is a key alternative to Premarin, potentially gaining market share.
Importance 40.0 Sentiment 30.0
stock
Reliance Industries
Reliance's Netmeds pharmacy lists Premarin as out of stock, but impact is minimal.
Importance 10.0 Sentiment 0.0
priv
Tata Group
Tata 1MG pharmacy lists Premarin as out of stock, but impact is minimal.
Importance 10.0 Sentiment 0.0
per
Sukhpreet Patel
Gynecologist and founder of MenopauseWize, noted patient complaints and limited alternatives.
Importance 10.0 Sentiment 0.0
per
Trupti Wagh
Pfizer's senior director of media relations for APAC, confirmed supply challenges.
Importance 10.0 Sentiment 0.0
curr
United States — United States dollar
Conversion rate used for reporting; no direct impact.
Importance 5.0 Sentiment 0.0
curr
India — Indian rupee
Sales figures reported in rupees; no direct impact on currency.
Importance 5.0 Sentiment 0.0
priv
Grand View Research
Provided market size estimates for estrogen therapy market.
Importance 5.0 Sentiment 0.0
ngo
Canadian Menopause Society
Cited population estimates; no direct role in event.
Importance 5.0 Sentiment 0.0
priv
Pharmarack
Provided sales data on Premarin in India.
Importance 5.0 Sentiment 0.0
priv
MedPlus
Online pharmacy listing Premarin as out of stock.
Importance 5.0 Sentiment 0.0
priv
Netmeds
Online pharmacy listing Premarin as out of stock.
Importance 5.0 Sentiment 0.0
priv
Truemeds
Online pharmacy listing Premarin as out of stock.
Importance 5.0 Sentiment 0.0
+ 3 more entities View on Dashboard
Relationships
India related ↔ Reliance Industries
India related ↔ Tata Group
Reliance Industries related ↔ Tata Group
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.